Abstract
Objectives Healthcare workers have a greater exposure to individuals with confirmed SARS-novel coronavirus 2, and an estimated 5-fold higher probability of contracting coronavirus disease (COVID)-19, than the general population. Many organisations have called for risk assessments to be put in place to minimise this risk. We wished to explore the predictive role of basic demographics in order to establish a simple tool that could help risk stratify healthcare workers.
Setting We undertook a review of the published literature (including multiple search strategies in MEDLINE with PubMed interface) and critically assessed early reports on medRxiv, a pre-print server (https://www.medrxiv.org: date of last search: December 21, 2020). We explored the relative risk of mortality from readily available demographics in order to identify the population at highest risk.
Results The only published studies specifically assessing the risk of healthcare workers had limited demographics available, therefore we explored the general population in the literature.
Clinician Demographics Mortality increased with increasing age from 50 years onwards. Male sex at birth, people of black and minority ethnicity groups had higher susceptibility to both hospitalisation and mortality. Co-morbid Disease. Vascular disease, renal disease, diabetes and chronic pulmonary disease further increased risk.
Risk stratification tool A risk stratification tool was compiled using a Caucasian female <50years with no comorbidities as a reference. A point allocated to risk factors associated with an approximate doubling in risk. This tool provides numerical support for healthcare workers when determining which team members should be allocated to patient facing clinical duties compared to remote supportive roles.
Conclusions We have generated a tool which can provide a framework for objective risk stratification of doctors and health care professionals during the COVID-19 pandemic, without requiring disclosure of information that an individual may not wish to share with their direct line manager during the risk assessment process.
Strengths and limitations of this study
There is an increased risk of mortality in the clinical workforce due to the effects of COVID-19.
This manuscript outlines a simple risk stratification tool that helps to quantify an individual’s biological risk
This will assist team leaders when allocating roles within clinical departments.
This tool does not incorporate other external factors, such as high-risk household members or those at higher risk of mental health issues, that may require additional consideration when allocating clinical duties in an appropriate clinical domain.
This population-based analysis did not explain for the very high risk observed in BAME healthcare workers suggesting there are other issues at play that require addressing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This performed a secondary analysis of existing data. No new data were produced
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
There is no new data - this represents an analysis of published data
